Senate Finance Committee investigating J&J
Executive Summary
The Senate Finance Committee is seeking information from Johnson & Johnson on medical education activities the company funded for its heartburn drug Propulsid (cisapride). A July 5 letter to the company from committee Chairman Charles Grassley (R-Iowa) and Ranking Member Max Baucus (D-Mont.) cites a June New York Times article discussing promotion of Propulsid's use in children before the company ceased marketing the product in 2000. The committee asks J&J to identify specific dollar amounts for educational grants and employees responsible for those grants between 1993 and 2000...
You may also be interested in...
Sales/Marketing Sway In Educational Grants Under Scrutiny By Senate
The Senate Finance Committee is asking drug companies to explain the role sales and marketing executives play in educational grants bestowed to professional societies
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.